The Hepatic oncology team reviews for The Lancet the treatment of Hepatocellular carcinoma
Hepatocellular carcinoma is the sixth most prevalent cancer and the third most frequent cause of cancer-related death. The team led by Dr. Jordi...
Hepatocellular carcinoma is the sixth most prevalent cancer and the third most frequent cause of cancer-related death. The team led by Dr. Jordi...
Myelofibrosis is a rare spontaneous disease that affects bone marrow progenitor cells. In 2005 researchers discovered that 60% of patients carry an...
Dr. Francisco Fernandez-Avilés offered on Monday February 20th an IDIBAPS Seminar about stem cell therapy for cardiac repair. He offered a wide per...
Life expectancy in developed countries has increased leading to a growing prevalence of diseases associated with aging, such as cardiovascular and...
DIRECT (DIabetes REsearCh for patient straTification), a consortium funded by the Innovative Medicines Initiative (IMI), announced today the launch...
Many drinkers who regularly consume large amounts of alcohol are unaware that they are reaching dangerous levels of alcohol intake. At present, acc...
A clinical trial published in The American Journal of Clinical Nutrition (AJCN), headed by doctors and researchers of the Department of Internal Me...
Three consecutive papers in Nature Protocols, EMBO Journal and Molecular Biology of the Cell position the IDIBAPS group Proliferation and cell sig...